Current Parkinson’s disease drugs improve the motor symptoms without influencing the underlying pathology or the natural history. Serendipitous research identified disease modifying properties for Parkinson’s disease in drugs prescribed for unrelated conditions. This has led to detailed studies of animal models, retrospective analyses of large clinical databases, and some clinical trials, to investigate their future potential.
This content is restricted to site members. If you are an existing user, please log in. New users may register below.